TY - JOUR AU - O’Leary, B. AU - Finn, R. S. AU - Turner, N. C. PY - 2016 DA - 2016// TI - Treating cancer with selective CDK4/6 inhibitors JO - Nat Rev Clin Oncol. VL - 13 UR - https://doi.org/10.1038/nrclinonc.2016.26 DO - 10.1038/nrclinonc.2016.26 ID - O’Leary2016 ER - TY - JOUR AU - Hertzman Johansson, C. AU - Egyhazi, B. r. a. g. e. S. PY - 2014 DA - 2014// TI - BRAF inhibitors in cancer therapy JO - Pharmacol Ther VL - 142 UR - https://doi.org/10.1016/j.pharmthera.2013.11.011 DO - 10.1016/j.pharmthera.2013.11.011 ID - Hertzman Johansson2014 ER - TY - JOUR AU - Reck, M. AU - Rodriguez-Abreu, D. AU - Robinson, A. G. AU - Hui, R. AU - Csoszi, T. AU - Fulop, A. PY - 2016 DA - 2016// TI - Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1606774 DO - 10.1056/NEJMoa1606774 ID - Reck2016 ER - TY - JOUR AU - Im, S. A. AU - Lu, Y. S. AU - Bardia, A. AU - Harbeck, N. AU - Colleoni, M. AU - Franke, F. PY - 2019 DA - 2019// TI - Overall survival with ribociclib plus endocrine therapy in breast cancer JO - N Engl J Med VL - 381 UR - https://doi.org/10.1056/NEJMoa1903765 DO - 10.1056/NEJMoa1903765 ID - Im2019 ER - TY - JOUR AU - Kornblum, N. AU - Zhao, F. AU - Manola, J. AU - Klein, P. AU - Ramaswamy, B. AU - Brufsky, A. PY - 2018 DA - 2018// TI - Randomized phase II trial of fulvestrant plus everolimus or placebo in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer resistant to aromatase inhibitor therapy: results of PrE0102 JO - J Clin Oncol VL - 36 UR - https://doi.org/10.1200/JCO.2017.76.9331 DO - 10.1200/JCO.2017.76.9331 ID - Kornblum2018 ER - TY - JOUR AU - Cross, D. A. AU - Ashton, S. E. AU - Ghiorghiu, S. AU - Eberlein, C. AU - Nebhan, C. A. AU - Spitzler, P. J. PY - 2014 DA - 2014// TI - AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer JO - Cancer Discov VL - 4 UR - https://doi.org/10.1158/2159-8290.CD-14-0337 DO - 10.1158/2159-8290.CD-14-0337 ID - Cross2014 ER - TY - JOUR AU - Johnson, D. B. AU - Menzies, A. M. AU - Zimmer, L. AU - Eroglu, Z. AU - Ye, F. AU - Zhao, S. PY - 2015 DA - 2015// TI - Acquired BRAF inhibitor resistance: a multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms JO - Eur J Cancer VL - 51 UR - https://doi.org/10.1016/j.ejca.2015.08.022 DO - 10.1016/j.ejca.2015.08.022 ID - Johnson2015 ER - TY - JOUR AU - Brady, S. W. AU - McQuerry, J. A. AU - Qiao, Y. AU - Piccolo, S. R. AU - Shrestha, G. AU - Jenkins, D. F. PY - 2017 DA - 2017// TI - Combating subclonal evolution of resistant cancer phenotypes JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/s41467-017-01174-3 DO - 10.1038/s41467-017-01174-3 ID - Brady2017 ER - TY - JOUR AU - Janiszewska, M. PY - 2019 DA - 2019// TI - The microcosmos of intratumor heterogeneity: the space-time of cancer evolution JO - Oncogene. VL - 39 UR - https://doi.org/10.1038/s41388-019-1127-5 DO - 10.1038/s41388-019-1127-5 ID - Janiszewska2019 ER - TY - JOUR AU - Kim, C. AU - Gao, R. AU - Sei, E. AU - Brandt, R. AU - Hartman, J. AU - Hatschek, T. PY - 2018 DA - 2018// TI - Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing JO - Cell. VL - 173 UR - https://doi.org/10.1016/j.cell.2018.03.041 DO - 10.1016/j.cell.2018.03.041 ID - Kim2018 ER - TY - JOUR AU - Koren, S. AU - Bentires-Alj, M. PY - 2015 DA - 2015// TI - Breast tumor heterogeneity: source of fitness, hurdle for therapy JO - Mol Cell VL - 60 UR - https://doi.org/10.1016/j.molcel.2015.10.031 DO - 10.1016/j.molcel.2015.10.031 ID - Koren2015 ER - TY - JOUR AU - Choi, S. AU - Henderson, M. J. AU - Kwan, E. AU - Beesley, A. H. AU - Sutton, R. AU - Bahar, A. Y. PY - 2007 DA - 2007// TI - Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone JO - Blood VL - 110 UR - https://doi.org/10.1182/blood-2007-01-067785 DO - 10.1182/blood-2007-01-067785 ID - Choi2007 ER - TY - JOUR AU - Kim, H. AU - Zheng, S. AU - Amini, S. S. AU - Virk, S. M. AU - Mikkelsen, T. AU - Brat, D. J. PY - 2015 DA - 2015// TI - Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution JO - Genome Res VL - 25 UR - https://doi.org/10.1101/gr.180612.114 DO - 10.1101/gr.180612.114 ID - Kim2015 ER - TY - JOUR AU - Li, B. AU - Brady, S. W. AU - Ma, X. AU - Shen, S. AU - Zhang, Y. AU - Li, Y. PY - 2019 DA - 2019// TI - Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia JO - Blood. VL - 135 UR - https://doi.org/10.1182/blood.2019002220 DO - 10.1182/blood.2019002220 ID - Li2019 ER - TY - JOUR AU - Gatenby, R. A. PY - 2009 DA - 2009// TI - A change of strategy in the war on cancer JO - Nature VL - 459 UR - https://doi.org/10.1038/459508a DO - 10.1038/459508a ID - Gatenby2009 ER - TY - JOUR AU - Gatenby, R. A. AU - Brown, J. AU - Vincent, T. PY - 2009 DA - 2009// TI - Lessons from applied ecology: cancer control using an evolutionary double bind JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-09-1354 DO - 10.1158/0008-5472.CAN-09-1354 ID - Gatenby2009 ER - TY - JOUR AU - West, J. B. AU - Dinh, M. N. AU - Brown, J. S. AU - Zhang, J. AU - Anderson, A. R. AU - Gatenby, R. A. PY - 2019 DA - 2019// TI - Multidrug cancer therapy in metastatic castrate-resistant prostate cancer: an evolution-based strategy JO - Clin Cancer Res VL - 25 UR - https://doi.org/10.1158/1078-0432.CCR-19-0006 DO - 10.1158/1078-0432.CCR-19-0006 ID - West2019 ER - TY - JOUR AU - Ricci, F. AU - Guffanti, F. AU - Damia, G. AU - Broggini, M. PY - 2017 DA - 2017// TI - Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts JO - Mol Cancer. VL - 16 UR - https://doi.org/10.1186/s12943-017-0662-3 DO - 10.1186/s12943-017-0662-3 ID - Ricci2017 ER - TY - JOUR AU - Ramos, P. AU - Bentires-Alj, M. PY - 2015 DA - 2015// TI - Mechanism-based cancer therapy: resistance to therapy, therapy for resistance JO - Oncogene VL - 34 UR - https://doi.org/10.1038/onc.2014.314 DO - 10.1038/onc.2014.314 ID - Ramos2015 ER - TY - JOUR AU - Bacevic, K. AU - Noble, R. AU - Soffar, A. AU - Wael Ammar, O. AU - Boszonyik, B. AU - Prieto, S. PY - 2017 DA - 2017// TI - Spatial competition constrains resistance to targeted cancer therapy JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/s41467-017-01516-1 DO - 10.1038/s41467-017-01516-1 ID - Bacevic2017 ER - TY - JOUR AU - Gatenby, R. A. AU - Silva, A. S. AU - Gillies, R. J. AU - Frieden, B. R. PY - 2009 DA - 2009// TI - Adaptive therapy JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-3658 DO - 10.1158/0008-5472.CAN-08-3658 ID - Gatenby2009 ER - TY - JOUR AU - Zhang, J. AU - Cunningham, J. J. AU - Brown, J. S. AU - Gatenby, R. A. PY - 2017 DA - 2017// TI - Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/s41467-017-01968-5 DO - 10.1038/s41467-017-01968-5 ID - Zhang2017 ER - TY - JOUR AU - Dhawan, A. AU - Nichol, D. AU - Kinose, F. AU - Abazeed, M. E. AU - Marusyk, A. AU - Haura, E. B. PY - 2017 DA - 2017// TI - Collateral sensitivity networks reveal evolutionary instability and novel treatment strategies in ALK mutated non-small cell lung cancer JO - Sci Rep. VL - 7 UR - https://doi.org/10.1038/s41598-017-00791-8 DO - 10.1038/s41598-017-00791-8 ID - Dhawan2017 ER - TY - JOUR AU - Zhao, B. AU - Sedlak, J. C. AU - Srinivas, R. AU - Creixell, P. AU - Pritchard, J. R. AU - Tidor, B. PY - 2016 DA - 2016// TI - Exploiting temporal collateral sensitivity in tumor clonal evolution JO - Cell VL - 165 UR - https://doi.org/10.1016/j.cell.2016.01.045 DO - 10.1016/j.cell.2016.01.045 ID - Zhao2016 ER - TY - JOUR AU - Soria, J. C. AU - Ohe, Y. AU - Vansteenkiste, J. AU - Reungwetwattana, T. AU - Chewaskulyong, B. AU - Lee, K. H. PY - 2018 DA - 2018// TI - Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer JO - N Engl J Med VL - 378 UR - https://doi.org/10.1056/NEJMoa1713137 DO - 10.1056/NEJMoa1713137 ID - Soria2018 ER - TY - JOUR AU - Long, G. V. AU - Stroyakovskiy, D. AU - Gogas, H. AU - Levchenko, E. AU - Braud, F. AU - Larkin, J. PY - 2015 DA - 2015// TI - Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial JO - Lancet VL - 386 UR - https://doi.org/10.1016/S0140-6736(15)60898-4 DO - 10.1016/S0140-6736(15)60898-4 ID - Long2015 ER - TY - JOUR AU - Lazar, V. AU - Martins, A. AU - Spohn, R. AU - Daruka, L. AU - Grezal, G. AU - Fekete, G. PY - 2018 DA - 2018// TI - Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides JO - Nat Microbiol. VL - 3 UR - https://doi.org/10.1038/s41564-018-0164-0 DO - 10.1038/s41564-018-0164-0 ID - Lazar2018 ER - TY - JOUR AU - Dobin, A. AU - Davis, C. A. AU - Schlesinger, F. AU - Drenkow, J. AU - Zaleski, C. AU - Jha, S. PY - 2013 DA - 2013// TI - STAR: ultrafast universal RNA-seq aligner JO - Bioinformatics VL - 29 UR - https://doi.org/10.1093/bioinformatics/bts635 DO - 10.1093/bioinformatics/bts635 ID - Dobin2013 ER - TY - JOUR AU - Li, B. AU - Dewey, C. N. PY - 2011 DA - 2011// TI - RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome JO - BMC Bioinform VL - 12 UR - https://doi.org/10.1186/1471-2105-12-323 DO - 10.1186/1471-2105-12-323 ID - Li2011 ER - TY - JOUR AU - Love, M. I. AU - Huber, W. AU - Anders, S. PY - 2014 DA - 2014// TI - Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 JO - Genome Biol VL - 15 UR - https://doi.org/10.1186/s13059-014-0550-8 DO - 10.1186/s13059-014-0550-8 ID - Love2014 ER - TY - JOUR AU - Hanzelmann, S. AU - Castelo, R. AU - Guinney, J. PY - 2013 DA - 2013// TI - GSVA: gene set variation analysis for microarray and RNA-seq data JO - BMC Bioinform VL - 14 UR - https://doi.org/10.1186/1471-2105-14-7 DO - 10.1186/1471-2105-14-7 ID - Hanzelmann2013 ER - TY - JOUR AU - Huang, W. AU - Sherman, B. T. AU - Lempicki, R. A. PY - 2009 DA - 2009// TI - Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources JO - Nat Protoc VL - 4 UR - https://doi.org/10.1038/nprot.2008.211 DO - 10.1038/nprot.2008.211 ID - Huang2009 ER - TY - JOUR AU - Bolger, A. M. AU - Lohse, M. AU - Usadel, B. PY - 2014 DA - 2014// TI - Trimmomatic: a flexible trimmer for Illumina sequence data JO - Bioinformatics VL - 30 UR - https://doi.org/10.1093/bioinformatics/btu170 DO - 10.1093/bioinformatics/btu170 ID - Bolger2014 ER - TY - JOUR AU - Li, H. AU - Durbin, R. PY - 2009 DA - 2009// TI - Fast and accurate short read alignment with Burrows-Wheeler transform JO - Bioinformatics VL - 25 UR - https://doi.org/10.1093/bioinformatics/btp324 DO - 10.1093/bioinformatics/btp324 ID - Li2009 ER - TY - JOUR AU - DePristo, M. A. AU - Banks, E. AU - Poplin, R. AU - Garimella, K. V. AU - Maguire, J. R. AU - Hartl, C. PY - 2011 DA - 2011// TI - A framework for variation discovery and genotyping using next-generation DNA sequencing data JO - Nat Genet VL - 43 UR - https://doi.org/10.1038/ng.806 DO - 10.1038/ng.806 ID - DePristo2011 ER - TY - JOUR AU - Li, H. AU - Handsaker, B. AU - Wysoker, A. AU - Fennell, T. AU - Ruan, J. AU - Homer, N. PY - 2009 DA - 2009// TI - The Sequence Alignment/Map format and SAMtools JO - Bioinformatics VL - 25 UR - https://doi.org/10.1093/bioinformatics/btp352 DO - 10.1093/bioinformatics/btp352 ID - Li2009 ER - TY - JOUR AU - Kim, S. AU - Scheffler, K. AU - Halpern, A. L. AU - Bekritsky, M. A. AU - Noh, E. AU - Kallberg, M. PY - 2018 DA - 2018// TI - Strelka2: fast and accurate calling of germline and somatic variants JO - Nat Methods VL - 15 UR - https://doi.org/10.1038/s41592-018-0051-x DO - 10.1038/s41592-018-0051-x ID - Kim2018 ER - TY - JOUR AU - Koboldt, D. C. AU - Zhang, Q. AU - Larson, D. E. AU - Shen, D. AU - McLellan, M. D. AU - Lin, L. PY - 2012 DA - 2012// TI - VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing JO - Genome Res VL - 22 UR - https://doi.org/10.1101/gr.129684.111 DO - 10.1101/gr.129684.111 ID - Koboldt2012 ER - TY - JOUR AU - Cingolani, P. AU - Platts, A. AU - Wang, L. AU - Coon, M. AU - Nguyen, T. AU - Wang, L. PY - 2012 DA - 2012// TI - A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3 JO - Fly (Austin). VL - 6 UR - https://doi.org/10.4161/fly.19695 DO - 10.4161/fly.19695 ID - Cingolani2012 ER - TY - JOUR AU - Wang, K. AU - Li, M. AU - Hakonarson, H. PY - 2010 DA - 2010// TI - ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data JO - Nucleic Acids Res VL - 38 UR - https://doi.org/10.1093/nar/gkq603 DO - 10.1093/nar/gkq603 ID - Wang2010 ER - TY - JOUR AU - Chen, X. AU - Chang, J. T. PY - 2017 DA - 2017// TI - Planning bioinformatics workflows using an expert system JO - Bioinformatics VL - 33 ID - Chen2017 ER - TY - JOUR AU - Weber, K. AU - Bartsch, U. AU - Stocking, C. AU - Fehse, B. PY - 2008 DA - 2008// TI - A multicolor panel of novel lentiviral “gene ontology” (LeGO) vectors for functional gene analysis JO - Mol Ther J Am Soc Gene Ther VL - 16 UR - https://doi.org/10.1038/mt.2008.6 DO - 10.1038/mt.2008.6 ID - Weber2008 ER - TY - JOUR AU - LaBarbera, D. V. AU - Reid, B. G. AU - Yoo, B. H. PY - 2012 DA - 2012// TI - The multicellular tumor spheroid model for high-throughput cancer drug discovery JO - Expert Opin Drug Discov VL - 7 UR - https://doi.org/10.1517/17460441.2012.708334 DO - 10.1517/17460441.2012.708334 ID - LaBarbera2012 ER - TY - JOUR AU - Sachs, N. AU - Ligt, J. AU - Kopper, O. AU - Gogola, E. AU - Bounova, G. AU - Weeber, F. PY - 2018 DA - 2018// TI - A living biobank of breast cancer organoids captures disease heterogeneity JO - Cell. VL - 172 UR - https://doi.org/10.1016/j.cell.2017.11.010 DO - 10.1016/j.cell.2017.11.010 ID - Sachs2018 ER - TY - JOUR AU - Leung, B. S. AU - Qureshi, S. AU - Leung, J. S. PY - 1982 DA - 1982// TI - Response to estrogen by the human mammary carcinoma cell line CAMA-1 JO - Cancer Res VL - 42 ID - Leung1982 ER - TY - JOUR AU - Kytola, S. AU - Rummukainen, J. AU - Nordgren, A. AU - Karhu, R. AU - Farnebo, F. AU - Isola, J. PY - 2000 DA - 2000// TI - Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping JO - Genes Chromosom Cancer VL - 28 UR - https://doi.org/3.0.CO;2-B DO - 3.0.CO;2-B ID - Kytola2000 ER - TY - JOUR AU - Grolmusz, V. K. AU - Toth, E. A. AU - Baghy, K. AU - Liko, I. AU - Darvasi, O. AU - Kovalszky, I. PY - 2016 DA - 2016// TI - Fluorescence activated cell sorting followed by small RNA sequencing reveals stable microRNA expression during cell cycle progression JO - BMC Genom VL - 17 UR - https://doi.org/10.1186/s12864-016-2747-6 DO - 10.1186/s12864-016-2747-6 ID - Grolmusz2016 ER - TY - JOUR AU - Grolmusz, V. K. AU - Karászi, K. AU - Micsik, T. AU - Tóth, E. A. AU - Mészáros, K. AU - Karvaly, G. PY - 2016 DA - 2016// TI - Cell cycle dependent RRM2 may serve as proliferation marker and pharmaceutical target in adrenocortical cancer JO - Am J Cancer Res VL - 6 ID - Grolmusz2016 ER - TY - JOUR AU - Yang, C. AU - Li, Z. AU - Bhatt, T. AU - Dickler, M. AU - Giri, D. AU - Scaltriti, M. PY - 2017 DA - 2017// TI - Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence JO - Oncogene VL - 36 UR - https://doi.org/10.1038/onc.2016.379 DO - 10.1038/onc.2016.379 ID - Yang2017 ER - TY - JOUR AU - Herrera-Abreu, M. T. AU - Palafox, M. AU - Asghar, U. AU - Rivas, M. A. AU - Cutts, R. J. AU - Garcia-Murillas, I. PY - 2016 DA - 2016// TI - Early adaptation and acquired resistance to CDK4/6 inhibition in estrogen receptor-positive breast cancer JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-15-0728 DO - 10.1158/0008-5472.CAN-15-0728 ID - Herrera-Abreu2016 ER - TY - JOUR AU - Condorelli, R. AU - Spring, L. AU - O’Shaughnessy, J. AU - Lacroix, L. AU - Bailleux, C. AU - Scott, V. PY - 2018 DA - 2018// TI - Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer JO - Ann Oncol VL - 29 UR - https://doi.org/10.1093/annonc/mdx784 DO - 10.1093/annonc/mdx784 ID - Condorelli2018 ER - TY - JOUR AU - Qiao, M. AU - Shapiro, P. AU - Fosbrink, M. AU - Rus, H. AU - Kumar, R. AU - Passaniti, A. PY - 2006 DA - 2006// TI - Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation JO - J Biol Chem VL - 281 UR - https://doi.org/10.1074/jbc.M508162200 DO - 10.1074/jbc.M508162200 ID - Qiao2006 ER - TY - JOUR AU - Zhao, J. AU - Tang, H. AU - Zhao, H. AU - Che, W. AU - Zhang, L. AU - Liang, P. PY - 2015 DA - 2015// TI - SEMA6A is a prognostic biomarker in glioblastoma JO - Tumour Biol VL - 36 UR - https://doi.org/10.1007/s13277-015-3584-y DO - 10.1007/s13277-015-3584-y ID - Zhao2015 ER - TY - JOUR AU - Hilvo, M. AU - Santiago, I. AU - Gopalacharyulu, P. AU - Schmitt, W. D. AU - Budczies, J. AU - Kuhberg, M. PY - 2016 DA - 2016// TI - Accumulated metabolites of hydroxybutyric acid serve as diagnostic and prognostic biomarkers of ovarian high-grade serous carcinomas JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-15-2298 DO - 10.1158/0008-5472.CAN-15-2298 ID - Hilvo2016 ER - TY - JOUR AU - Lu, W. AU - Wang, X. AU - Liu, J. AU - He, Y. AU - Liang, Z. AU - Xia, Z. PY - 2016 DA - 2016// TI - Downregulation of ARHGDIA contributes to human glioma progression through activation of Rho GTPase signaling pathway JO - Tumour Biol. VL - 37 UR - https://doi.org/10.1007/s13277-016-5374-6 DO - 10.1007/s13277-016-5374-6 ID - Lu2016 ER - TY - JOUR AU - Gallaher, J. A. AU - Enriquez-Navas, P. M. AU - Luddy, K. A. AU - Gatenby, R. A. AU - Anderson, A. R. A. PY - 2018 DA - 2018// TI - Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies JO - Cancer Res VL - 78 UR - https://doi.org/10.1158/0008-5472.CAN-17-2649 DO - 10.1158/0008-5472.CAN-17-2649 ID - Gallaher2018 ER - TY - JOUR AU - O’Connell, M. J. AU - Walworth, N. C. AU - Carr, A. M. PY - 2000 DA - 2000// TI - The G2-phase DNA-damage checkpoint JO - Trends Cell Biol VL - 10 UR - https://doi.org/10.1016/S0962-8924(00)01773-6 DO - 10.1016/S0962-8924(00)01773-6 ID - O’Connell2000 ER - TY - JOUR AU - Lee, J. H. AU - Paull, T. T. PY - 2007 DA - 2007// TI - Activation and regulation of ATM kinase activity in response to DNA double-strand breaks JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210872 DO - 10.1038/sj.onc.1210872 ID - Lee2007 ER - TY - JOUR AU - Reinhardt, H. C. AU - Aslanian, A. S. AU - Lees, J. A. AU - Yaffe, M. B. PY - 2007 DA - 2007// TI - p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage JO - Cancer Cell VL - 11 UR - https://doi.org/10.1016/j.ccr.2006.11.024 DO - 10.1016/j.ccr.2006.11.024 ID - Reinhardt2007 ER - TY - JOUR AU - Knight, T. AU - Luedtke, D. AU - Edwards, H. AU - Taub, J. W. AU - Ge, Y. PY - 2019 DA - 2019// TI - A delicate balance—The BCL-2 family and its role in apoptosis, oncogenesis, and cancer therapeutics JO - Biochem Pharmacol VL - 162 UR - https://doi.org/10.1016/j.bcp.2019.01.015 DO - 10.1016/j.bcp.2019.01.015 ID - Knight2019 ER - TY - JOUR AU - Fu, S. AU - Wang, Y. AU - Keyomarsi, K. AU - Meric-Bernstam, F. AU - Meric-Bernstein, F. PY - 2018 DA - 2018// TI - Strategic development of AZD1775, a Wee1 kinase inhibitor, for cancer therapy JO - Expert Opin Investig Drugs VL - 27 UR - https://doi.org/10.1080/13543784.2018.1511700 DO - 10.1080/13543784.2018.1511700 ID - Fu2018 ER - TY - JOUR AU - Matheson, C. J. AU - Backos, D. S. AU - Reigan, P. PY - 2016 DA - 2016// TI - Targeting WEE1 Kinase in Cancer JO - Trends Pharmacol Sci VL - 37 UR - https://doi.org/10.1016/j.tips.2016.06.006 DO - 10.1016/j.tips.2016.06.006 ID - Matheson2016 ER - TY - JOUR AU - Xu, D. AU - Liang, S. Q. AU - Yang, H. AU - Bruggmann, R. AU - Berezowska, S. AU - Yang, Z. PY - 2019 DA - 2019// TI - CRISPR screening identifies WEE1 as a combination target for standard chemotherapy in malignant pleural mesothelioma JO - Mol Cancer Ther. VL - 19 UR - https://doi.org/10.1158/1535-7163.MCT-19-0724 DO - 10.1158/1535-7163.MCT-19-0724 ID - Xu2019 ER - TY - JOUR AU - Biankin, A. V. AU - Waddell, N. AU - Kassahn, K. S. AU - Gingras, M. C. AU - Muthuswamy, L. B. AU - Johns, A. L. PY - 2012 DA - 2012// TI - Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes JO - Nature VL - 491 UR - https://doi.org/10.1038/nature11547 DO - 10.1038/nature11547 ID - Biankin2012 ER - TY - JOUR AU - Lu, D. AU - Wang, J. AU - Shi, X. AU - Yue, B. AU - Hao, J. PY - 2017 DA - 2017// TI - AHNAK2 is a potential prognostic biomarker in patients with PDAC JO - Oncotarget. VL - 8 UR - https://doi.org/10.18632/oncotarget.15990 DO - 10.18632/oncotarget.15990 ID - Lu2017 ER - TY - JOUR AU - Zhang, M. AU - Iyer, R. R. AU - Azad, T. D. AU - Wang, Q. AU - Garzon-Muvdi, T. AU - Wang, J. PY - 2019 DA - 2019// TI - Genomic landscape of intramedullary spinal cord gliomas JO - Sci Rep. VL - 9 UR - https://doi.org/10.1038/s41598-019-54286-9 DO - 10.1038/s41598-019-54286-9 ID - Zhang2019 ER - TY - JOUR AU - Cai, M. AU - Liang, X. AU - Sun, X. AU - Chen, H. AU - Dong, Y. AU - Wu, L. PY - 2019 DA - 2019// TI - Nuclear receptor coactivator 2 promotes human breast cancer cell growth by positively regulating the MAPK/ERK Pathway JO - Front Oncol. VL - 9 UR - https://doi.org/10.3389/fonc.2019.00164 DO - 10.3389/fonc.2019.00164 ID - Cai2019 ER - TY - JOUR AU - Yin, J. AU - Fu, W. AU - Dai, L. AU - Jiang, Z. AU - Liao, H. AU - Chen, W. PY - 2017 DA - 2017// TI - ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1 JO - Sci Rep. VL - 7 UR - https://doi.org/10.1038/s41598-017-04818-y DO - 10.1038/s41598-017-04818-y ID - Yin2017 ER -